ADVISORY BOARD

 Prof. Irun Cohen, M.D.

Irun R. Cohen, MD, was trained as a physician and did a residency in pediatrics.  Since 1968, he has been involved in research in immunology.  He has been the Mauerberger Professor of Immunology at the Department of Immunology of the Weizmann Institute of Science; Director, European Collaboration on T Cell Vaccination; Director, Robert Koch-Minerva Center for Research in Autoimmune Diseases; Director, Center for the Study of Emerging Diseases, Jerusalem; Member, Committees for Planning new medical schools in Beer Sheva and, now, in the Galilee; Chairman, Committee for the Re-accreditation of Israeli Medical Schools; and Director of the National Institute of Biotechnology in the Negev, Ben-Gurion University of the Negev, among other responsibilities. 

He is a highly cited researcher with over 500 professional publications. Irun Cohen made seminal contributions in the field of immunology including his work on system’s immunology and autoimmunity. For his work on autoimmunity, Irun Cohen has been awarded the Robert Koch Prize (Germany), the Teva Founders Prize, the AESKU Prize and a European Federation of Immunological Societies Prize, among others.

 

 

Georg Mann, M.D.

Georg Mann was born in Vienna and received his training in general medicine in 1985 and in pediatrics in 1990. He received a special education in pediatric hematology and oncology at the University Medical School, Innsbruck, and at the St. Anna Children Hospital, Vienna, Austria. He has been serving as the coordinator of the Austrian studies for treatment of childhood acute lymphoblastic leukemias and has been chair of studies for treatment of Non-Hodgkin’s lymphomas in childhood in Austria. He is a Associate Professor of Pediatrics and of Pediatric Hematology and Oncology certified by the Austrian Society of Physicians and has been the interim director and vice director of the St. Anna’s Children Hospital.

Georg Mann has a substantial publication record (>60) in the field of pediatric cancer and hematology.

Being member of several national and international societies of pediatric leukemias and lymphomas, and leading Austrian representative in the international BFM trials of childhood acute lymphoblastic leukemias, Non-Hodgkin’s lymphomas  and Hodgkin’s Disease he made significant contributions for improving treatment options in these malignancies.

.





 

Project Title: MODICELL

Project No.: 285875

Coordinator: Andreas Heitger

Start: 01/01/2013

Duration: 48 months

Contact: office@modicell.eu

CORDIS: Project Details


LEGAL DETAILS & CONTACT

The Project recieves funding from the European Union FP7-People Programme under grant agreement n° 285875

© MODICELL 2013, Webdesign by BIOLUTION